Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 49 M44 M48 M52 M60 M58 M 218 M Research & development 275 M282 M304 M290 M323 M207 M 1.12 B Operating income -117 M-74 M-109 M-140 M-3.9 B-30 M -4.17 B Non-Operating Income, Total 2 M6 M09 M2 M7 M 18 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 2 M6 M09 M2 M7 M 18 M Unusual income/expense —————— — Pretax income -99 M-61 M-92 M-125 M-3.88 B-17 M -4.12 B Equity in earnings —————— — Taxes 3 M6 M4 M2 M-64 M4 M -54 M Non-controlling/minority interest —————— — After tax other income/expense ——-1 M-4 M—— — Net income before discontinued operations -102 M-67 M-96 M-127 M-3.82 B-21 M -4.06 B Discontinued operations —————— — Net income -102 M-67 M-96 M-127 M-3.82 B-21 M -4.06 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -102 M-67 M-96 M-127 M-3.82 B-21 M -4.06 B Basic earnings per share (Basic EPS) -0.13-0.08-0.12-0.15-4.68-0.03 -4.98 Diluted earnings per share (Diluted EPS) -0.13-0.08-0.12-0.15-4.68-0.03 -4.98 Average basic shares outstanding 812 M812 M814 M813 M817 M818 M — Diluted shares outstanding 812 M812 M814 M813 M817 M818 M — EBITDA -99 M-56 M-91 M-120 M-3.88 B-8 M -4.09 B EBIT -117 M-74 M-109 M-140 M-3.9 B-30 M -4.17 B Cost of revenue 231 M254 M261 M244 M283 M273 M 1.06 B Other cost of goods sold 1 M1 M0000 0 Depreciation & amortization (cash flow) 18 M18 M18 M20 M20 M22 M 80 M